Furthermore, the ligands of NKG2D can be induced or upregulated by chemotherapeutic agents or radiation therapy (53, 54); thus, the combination therapy of CIK cells with these traditional modalities might have synergistic benefits for cancer patients and further studies are needed in this regard. This evidence concerns the gene KLRK1 and cancer.